Support stronger IP and exclusivity protections and enforcement in foreign markets Trade-related aspects of Intellectual Property (TRIPS) Waiver, no related bill number Issues related to tax reform and tax policy Implementation of Tax Cuts and Jobs Act of 2017 (P.L.115-97) American Innovations and Jobs Act issues related to OECD negotiations on the taxation of global income Drug cost and pricing policy S.1967, PBM Act S.1542, DRUG Act H.R.5539, ORPHAN Cures Act Education and discussions regarding pharmaceutical issues related to supply chain H.R.830, HELP Copays Act Issues related to the 340B program reforms Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis and appropriations, PET scan coverage and reimbursement, and dementia care Inflation Reduction Act implementation (P.L.117-1769), including provisions related to corporate taxes, Medicare, research and development, and prescription drug pricing The Mental Health Professionals Workforce Shortage Loan Repayment Act S.1214, RARE Act S.3558, BioSecure Act
CPT - Copyright/Patent/Trademark TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code PHA - Pharmacy MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
JONATHAN CAUSEY DANIEL HARDER DANIEL HARDER DANIEL HARDER DANIEL HARDER JONATHAN CAUSEY JONATHAN CAUSEY TYLER HANSON DANIEL HARDER ALI LAKHANI JOHN RAYMOND GIBSON JONATHAN CAUSEY